Provided by Tiger Trade Technology Pte. Ltd.

iRadimed

87.87
+0.69000.79%
Post-market: 87.870.00000.00%16:10 EDT
Volume:88.00K
Turnover:7.76M
Market Cap:1.12B
PE:49.09
High:89.13
Open:87.29
Low:85.74
Close:87.18
52wk High:107.90
52wk Low:67.84
Shares:12.79M
Float Shares:8.31M
Volume Ratio:1.08
T/O Rate:1.06%
Dividend:0.77
Dividend Rate:0.88%
EPS(TTM):1.79
EPS(LYR):1.75
ROE:23.52%
ROA:15.56%
PB:11.04
PE(LYR):50.21

Loading ...

IRadimed CEO Roger E. Susi disposes of 2,500 common shares worth $226,204.11

Reuters
·
Jun 03

IRadimed CEO Roger E. Susi disposes of common shares worth $689,981.05

Reuters
·
May 29

IRadimed CEO Roger E. Susi disposes 7,500 shares worth $659,902.20

Reuters
·
May 21

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

GlobeNewswire
·
May 20

IRadimed CEO Roger E. Susi disposes 7,500 shares for $635,776

Reuters
·
May 14

The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why

Simply Wall St.
·
May 11

IRadimed CEO Roger E. Susi sells USD 638,299 common shares

Reuters
·
May 07

Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD?

Simply Wall St.
·
May 04

Stock Track | iRadimed Soars 5.20% Intraday on Strong Q1 Earnings Beat and Successful New Product Launch

Stock Track
·
May 02

Stock Track | iRadimed Plummets 7.77% Intraday Despite Q1 Earnings Beat on Guidance Concerns

Stock Track
·
May 01

IRadimed Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

iRadimed backs FY26 EPS view $2.06-$2.21, consensus $2.08

TIPRANKS
·
May 01

IRadimed Q1 revenue rises 13% on new product launch

Reuters
·
May 01

GUIDANCE: (IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.06 to $2.21, vs. FactSet Est of $2.08

MT Newswires Live
·
May 01

GUIDANCE: (IRMD) IRadimed Expects 2026 Revenue Range $91.0M to $96.0M, vs. FactSet Est of $92.3M

MT Newswires Live
·
May 01

iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate

Benzinga Earnings
·
May 01

BRIEF-IRadimed Q1 EPS USD 0.45

Reuters
·
May 01

IRadimed Corp: Reaffirms Full-Year 2026 Revenue and Earnings Guidance

THOMSON REUTERS
·
May 01

IRADIMED CORPORATION Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 01

IRadimed CEO Roger E. Susi disposes of 7,500 shares worth $655,536

Reuters
·
May 01